Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1603466 STAMFORD, CT
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,790,425
+$18,790,425 QoQ
Shares Held
506,344
Ownership
0.848%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#35
of 238 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Mar 31, 2026
CallValue
$497,301
CallShares
14,700
PutValue
$497,301
PutShares
14,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. AGIO ranks #36 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in AGIO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,790,425 506,344
2026-03-31 $497,301 14,700
2026-03-31 $497,301 14,700
2025-12-31 $5,444,000 200,000
2025-09-30 $261,190 6,507
2024-09-30 $6,664,500 150,000
2021-03-31 $5,220,804 101,100
2020-12-31 $7,782,068 179,600
2020-09-30 $16,724,820 477,852
2020-06-30 $17,822,691 333,259
2020-03-31 $4,634,184 130,614